in english
|
|
|
Peaesineja
- Prof. Dan Roden,
- Vanderbilt University Medical Center, USA
Esinejad
- Prof. Harri Alenius,
- Karolinska Institute, Rootsi
- Prof. Ole Andreassen,
- University of Oslo, Institute of Clinical Medicine, Norra
- Toomas Asser,
- Rector, University of Tartu, Eesti
- Prof. Peer Bork,
- EMBL, Heidelberg, Saksamaa
- Prof. Erik Eliasson,
- Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Rootsi
- Prof. Stefan Fröhling,
- Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) Heidelberg, Saksamaa
- Dr. Mathew Garnett,
- Wellcome Sanger Institute, UK
- Prof. Henk-Jan Guchelaar,
- Leiden University Medical Center, The Netherlands
- Prof. Margit Mahlapuu,
- University of Gothenburg, Rootsi
- Prof. Iain Mathieson,
- University of Pennsylvania, USA
- Dr. Gregory Michelotti,
- Metabolon Inc., USA
- Prof. Lili Milani,
- Estonian Genome Center, Institute of Genomics, University of Tartu, Eesti
- Prof. Frode Norheim,
- Faculty of Medicine, University of Oslo, Norra
- Prof. Lluis Quintana-Murci,
- Institut Pasteur, Paris, Prantsusmaa
- Dr. Vardhman Rakyan,
- Blizard Institute, University of London, UK
- Prof. Heidi Rehm,
- Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA/ The Broad Institute of Harvard and MIT, Cambridge, MA, USA
- Dr. Carina Schlebusch,
- Evolutionary Biology Centre, Uppsala University, Rootsi
- Dr. Kerrin Small,
- King’s College London, UK
- Prof. Alexandra Zhernakova,
- University of Groningen, The Netherlands
|
